In the 1990s, interest in evaluating the outcomes of formulary restrictiveness-particularly its effect on health care resource utilization-has grown. Numerous studies have assessed the benefit of formularies.4-l5 Most of these investigations were conducted among Medicaid populations, examined only one or two therapy classes, or suffered from inadequate study design. .'6. 17 The Managed Care Outcomes Project, a multicenter observational investigation, is one of only two studies that have evaluated the outcomes of formulary restrictions using data derived from a noncMedicaid popu!ation9.lI However, this study has been criticized for methodological and analytical flaws. 18, 19 The most recent study to examine closed formularies used a pre-fpost-with control group design and examined a continuous1y eligible population of commercial enrollees within a pharmacy benefit management company. 20 
